{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T11:32:09Z","timestamp":1787052729081,"version":"build-2736575974"},"reference-count":116,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Over the past four decades, percutaneous coronary intervention (PCI) safety and efficacy have significantly improved, particularly with the advent of the drug-eluting stent (DES). First-generation DESs reduced in-stent restenosis rates and targeted lesion revascularization; however, safety issues emerged, due to high incidences of stent thrombosis (ST) linked to death, myocardial infarction, and repeat revascularization. Second-generation DESs were developed to overcome these issues, reducing late-thrombotic-event risk while maintaining anti-restenosis efficacy. Nevertheless, ST still occurs with second-generation DES use. Stent thrombosis etiology is multifaceted, encompassing lesion-, patient-, procedural-, and stent-related factors. Overall, most early-stent-thrombosis cases are linked to procedural and patient-related aspects. Factors like premature discontinuation of dual antiplatelet therapy, resistance to clopidogrel, smoking, diabetes mellitus, malignancy, reduced ejection fraction or undertaking coronary angioplasty for an acute coronary syndrome can increase the risk of stent thrombosis. The aim of this study is to assess patient-related factors that potentially heighten the risk of stent thrombosis, with the objective of pinpointing and addressing modifiable contributors to this risk. By focusing on both patient- and procedure-related factors, a multifaceted approach to coronary revascularization can help minimize complications and maximize long-term benefits in managing ST.<\/jats:p>","DOI":"10.3390\/jcm12237367","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T07:41:32Z","timestamp":1701157292000},"page":"7367","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Patient-Related Factors Predicting Stent Thrombosis in Percutaneous Coronary Interventions"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7925-3806","authenticated-orcid":false,"given":"Larisa","family":"Anghel","sequence":"first","affiliation":[{"name":"Internal Medicine Department, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700503 Ia\u0219i, Romania"},{"name":"Cardiology Department, Cardiovascular Diseases Institute \u201cProf. Dr. George I. M. Georgescu\u201d, 700503 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7687-8624","authenticated-orcid":false,"given":"Bogdan-Sorin","family":"Tudurachi","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700503 Ia\u0219i, Romania"},{"name":"Cardiology Department, Cardiovascular Diseases Institute \u201cProf. Dr. George I. M. Georgescu\u201d, 700503 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6775-0287","authenticated-orcid":false,"given":"Andreea","family":"Tudurachi","sequence":"additional","affiliation":[{"name":"Cardiology Department, Cardiovascular Diseases Institute \u201cProf. Dr. George I. M. Georgescu\u201d, 700503 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Z\u0103voi","sequence":"additional","affiliation":[{"name":"Cardiology Department, Cardiovascular Diseases Institute \u201cProf. Dr. George I. M. Georgescu\u201d, 700503 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Clement","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700503 Ia\u0219i, Romania"},{"name":"Cardiology Department, Cardiovascular Diseases Institute \u201cProf. Dr. George I. M. Georgescu\u201d, 700503 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8736-4094","authenticated-orcid":false,"given":"Alexandros","family":"Roungos","sequence":"additional","affiliation":[{"name":"Cardiology Department, Cardiovascular Diseases Institute \u201cProf. Dr. George I. M. Georgescu\u201d, 700503 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura-C\u0103t\u0103lina","family":"Benchea","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700503 Ia\u0219i, Romania"},{"name":"Cardiology Department, Cardiovascular Diseases Institute \u201cProf. Dr. George I. M. Georgescu\u201d, 700503 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana M\u0103d\u0103lina","family":"Zota","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700503 Ia\u0219i, Romania"},{"name":"Cardiology Department, Cardiovascular Diseases Institute \u201cProf. Dr. George I. M. Georgescu\u201d, 700503 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Prisacariu","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700503 Ia\u0219i, Romania"},{"name":"Cardiology Department, Cardiovascular Diseases Institute \u201cProf. Dr. George I. M. Georgescu\u201d, 700503 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu Andy","family":"Sasc\u0103u","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700503 Ia\u0219i, Romania"},{"name":"Cardiology Department, Cardiovascular Diseases Institute \u201cProf. Dr. George I. M. Georgescu\u201d, 700503 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6439-4561","authenticated-orcid":false,"given":"Cristian","family":"St\u0103tescu","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700503 Ia\u0219i, Romania"},{"name":"Cardiology Department, Cardiovascular Diseases Institute \u201cProf. Dr. George I. M. Georgescu\u201d, 700503 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: A case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e051121190712","DOI":"10.2174\/1573403X17666210126104053","article-title":"Efficacy and Safety Outcomes of Short Duration Antiplatelet Therapy with Early Cessation of Aspirin Post Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis","volume":"17","author":"Hutchings","year":"2021","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMoa2108749","article-title":"Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk","volume":"385","author":"Valgimigli","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4244\/EIJY19M01_01","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"14","author":"Neumann","year":"2019","journal-title":"EuroIntervention"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12928-021-00754-x","article-title":"Drug-eluting stent thrombosis: Current and future perspectives","volume":"36","author":"Kuramitsu","year":"2021","journal-title":"Cardiovasc. Interv. Ther."},{"key":"ref_7","first-page":"1704","article-title":"Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry","volume":"119","author":"Vogel","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"ref_8","first-page":"1034","article-title":"Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: An individual patient data pairwise and network meta-analysis of six randomized trials and 11,473 patients","volume":"38","author":"Palmerini","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/joic.12413","article-title":"High risk of stent thrombosis in the first 6 months after coronary stenting: Do not discontinue clopidogrel early after ACS","volume":"30","author":"Zwart","year":"2017","journal-title":"J. Interv. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/heartjnl-2018-313148","article-title":"Cessation of dual antiplatelet therapy and cardiovascular events following acute coronary syndrome","volume":"105","author":"Dawson","year":"2019","journal-title":"Heart"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0140-6736(18)31858-0","article-title":"Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: A multicentre, open-label, randomised superiority trial","volume":"392","author":"Vranckx","year":"2018","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1001\/jama.2019.8145","article-title":"Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Tria","volume":"321","author":"Watanabe","year":"2019","journal-title":"JAMA"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Parfrey, S., Abdelrahman, A., Blackman, D., Blaxill, J.M., Cunnington, M.S., Greenwood, J.P., Malkin, C.J., Mozid, A.M., Rossington, J.A., and Veerasamy, M. (2022). Safety and efficacy of interrupting dual antiplatelet therapy one month following percutaneous coronary intervention: A meta-analysis of randomized controlled trials. BMC Cardiovasc. Disord., 22.","DOI":"10.1186\/s12872-022-02900-6"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.amjcard.2018.07.041","article-title":"Dual Antiplatelet Therapy Cessation and Adverse Events after Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry)","volume":"122","author":"Sorrentino","year":"2018","journal-title":"Am. J. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e008226","DOI":"10.1161\/CIRCINTERVENTIONS.119.008226","article-title":"Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events after Percutaneous Coronary Intervention: The PARIS Registry","volume":"13","author":"Sorrentino","year":"2020","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e006144","DOI":"10.1161\/CIRCINTERVENTIONS.117.006144","article-title":"Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation among Patients with and without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results from the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients)","volume":"11","author":"Baber","year":"2018","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2020.04.014","article-title":"Comparison of One-Year Outcomes in Patients >75 versus \u226475 Years with Coronary Artery Disease Treated with COMBO Stents (From The MASCOT Registry)","volume":"127","author":"Chandrasekhar","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jcin.2019.02.033","article-title":"Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis from the PARIS Registry","volume":"12","author":"Joyce","year":"2019","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e027055","DOI":"10.1161\/JAHA.122.027055","article-title":"Long-Term Outcomes and Duration of Dual Antiplatelet Therapy after Coronary Intervention with Second-Generation Drug-Eluting Stents: The Veterans Affairs Extended DAPT Study","volume":"12","author":"Kinlay","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s11239-018-1699-x","article-title":"Predictors of coronary stent thrombosis: A case\u2013control study","volume":"46","author":"Silva","year":"2018","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e3530","DOI":"10.1002\/dmrr.3530","article-title":"Short-term dual antiplatelet therapy in diabetic patients admitted for acute coronary syndrome treated with a new-generation drug-eluting stent","volume":"38","author":"Vranken","year":"2022","journal-title":"Diabetes\/Metab. Res. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1002\/ccd.28467","article-title":"Contemporary management of stent thrombosis: Predictors of mortality and the role of new-generation drug-eluting stents","volume":"96","author":"Katsikis","year":"2020","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5334\/gh.1112","article-title":"Incidence, Predictors, and Outcomes of Acute and Sub-acute Stent Thrombosis after Emergency Percutaneous Coronary Revascularization with Drug-Eluting Stents: A Prospective Observational Study","volume":"17","author":"Kumar","year":"2022","journal-title":"Glob. Heart"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s12928-018-0516-y","article-title":"CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) in 2018","volume":"33","author":"Ozaki","year":"2018","journal-title":"Cardiovasc. Interv. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jcin.2014.11.002","article-title":"Acute stent thrombosis after primary percutaneous coronary intervention: Insights from the EUROMAX trial (European Ambulance Acute Coronary Syndrome Angiography)","volume":"8","author":"Clemmensen","year":"2015","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1016\/j.jacc.2014.02.607","article-title":"Causes of early stent thrombosis in patients presenting with acute coronary syndrome: An ex vivo human autopsy study","volume":"63","author":"Nakano","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jcin.2014.05.016","article-title":"Stent thrombosis: A clinical perspective","volume":"7","author":"Claessen","year":"2014","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1253\/circj.CJ-20-0674","article-title":"Identification of Patient-Related Factors in Stent Thrombosis","volume":"84","author":"Kohsaka","year":"2020","journal-title":"Circ. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/S0140-6736(13)61720-1","article-title":"Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study","volume":"382","author":"Mehran","year":"2013","journal-title":"Lancet"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1016\/j.jacc.2019.09.038","article-title":"Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction","volume":"74","author":"Chichareon","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jjcc.2019.01.012","article-title":"Five-year outcomes after first- and second-generation drug-eluting stent implantation in all patients undergoing percutaneous coronary intervention","volume":"74","author":"Yano","year":"2019","journal-title":"J. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"100427","DOI":"10.1016\/j.ijcha.2019.100427","article-title":"Acute and sub-acute stent thrombosis: Frequency, predictors and features in patients undergoing primary percutaneous intervention at a tertiary care cardiac centre","volume":"26","author":"Tariq","year":"2020","journal-title":"IJC Heart Vasc."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"256","DOI":"10.37616\/2212-5043.1024","article-title":"Validity of the Stent Thrombosis Risk Score in Predicting Early Stent Thrombosis after Primary Percutaneous Coronary Intervention","volume":"32","author":"Kumar","year":"2020","journal-title":"J. Saudi Heart Assoc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/ccd.27215","article-title":"Incidence, predictors, and clinical outcomes of early stent thrombosis in acute myocardial infarction patients treated with primary percutaneous coronary angioplasty (insights from the University of Ottawa Heart Institute STEMI registry)","volume":"91","author":"Singh","year":"2018","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s11239-020-02184-7","article-title":"Clinical outcomes after percutaneous coronary intervention for early versus late and very late stent thrombosis: A systematic review and meta-analysis","volume":"51","author":"Yang","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1055\/s-0039-3402758","article-title":"Effect of Smoking Cessation on the Pharmacokinetics and Pharmacodynamics of Clopidogrel after PCI: The Smoking Cessation Paradox Study","volume":"120","author":"Ramotowski","year":"2020","journal-title":"Thromb. Haemost."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"954","DOI":"10.5603\/CJ.a2020.0185","article-title":"Sex difference after acute myocardial infarction patients with a history of current smoking and long-term clinical outcomes: Results of KAMIR Registry","volume":"29","author":"Kim","year":"2022","journal-title":"Cardiol. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e005739","DOI":"10.1161\/JAHA.117.005739","article-title":"Sex and Outcomes after Percutaneous Coronary Intervention: A Cause for Concern for Young Women and Those with ST-Segment Elevation Myocardial Infarction?","volume":"6","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e28214","DOI":"10.1097\/MD.0000000000028214","article-title":"ST-segment elevation versus non-ST-segment elevation myocardial infarction in current smokers after newer-generation drug-eluting stent implantation","volume":"100","author":"Kim","year":"2021","journal-title":"Medicine"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Kim, Y.H., Her, A.-Y., Jeong, M.H., Kim, B.-K., Hong, S.-J., Shin, D.-H., Kim, J.-S., Ko, Y.-G., Choi, D., and Hong, M.-K. (2018). Impact of current smoking on 2-year clinical outcomes between durable-polymer-coated stents and biodegradable-polymer-coated stents in acute myocardial infarction after successful percutaneous coronary intervention: Data from the KAMIR. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0205046"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e007982","DOI":"10.1161\/CIRCINTERVENTIONS.119.007982","article-title":"Impact of Smoking on Platelet Reactivity and Clinical Outcomes after Percutaneous Coronary Intervention: Findings from the ADAPT-DES Study","volume":"12","author":"Gupta","year":"2019","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"918033","DOI":"10.3389\/fcvm.2022.918033","article-title":"Association between baseline smoking status and clinical outcomes following myocardial infarction","volume":"9","author":"Oh","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_43","first-page":"281","article-title":"Re-catheterization in a young patient with acute myocardial infarction: Is it preventable?","volume":"15","author":"Hazin","year":"2023","journal-title":"Am. J. Transl. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"E118","DOI":"10.9778\/cmajo.20210119","article-title":"Extended dual antiplatelet therapy following percutaneous coronary intervention in clinically important patient subgroups: A systematic review and meta-analysis","volume":"11","author":"Elliott","year":"2023","journal-title":"CMAJ Open"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.amjcard.2021.06.031","article-title":"Incidence and Predictors of Stent Thrombosis in Patients Treated with Stents for Coronary Bifurcation Narrowing (From the BIFURCAT Registry)","volume":"156","author":"Franchin","year":"2021","journal-title":"Am. J. Cardiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.jcin.2019.06.034","article-title":"The Smoker\u2019s Paradox Revisited: A Patient-Level Pooled Analysis of 18 Randomized Controlled Trials","volume":"12","author":"Yadav","year":"2019","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.amjcard.2011.09.016","article-title":"Outcome of Percutaneous Coronary Intervention Utilizing Drug-Eluting Stents in Patients with Reduced Left Ventricular Ejection Fraction","volume":"109","author":"Sardi","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.2016.3775","article-title":"Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year after Percutaneous Coronary Intervention","volume":"315","author":"Yeh","year":"2016","journal-title":"JAMA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, Predictors, and Outcome of Thrombosis after Successful Implantation of Drug-Eluting Stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.ahj.2005.08.011","article-title":"Bare metal stent restenosis is not a benign clinical entity","volume":"151","author":"Chen","year":"2006","journal-title":"Am. Heart J."},{"key":"ref_51","first-page":"320","article-title":"Coronary Stent Thrombosis\u2014Predictors and Prevention","volume":"117","author":"Ullrich","year":"2020","journal-title":"Dtsch. Aerzteblatt Online"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.amjcard.2008.04.049","article-title":"Safety of Drug-Eluting Stents in Patients with Left Ventricular Dysfunction Undergoing Percutaneous Coronary Intervention","volume":"102","author":"Nusca","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/jth.12538","article-title":"Platelet-reactivity tests identify patients at risk of secondary cardiovascular events: A systematic review and meta-analysis","volume":"12","author":"Wisman","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/dmd.31.1.53","article-title":"The Metabolism of Clopidogrel Is Catalyzed by Human Cytochrome P450 3A and Is Inhibited by Atorvastatin","volume":"31","author":"Clarke","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jacc.2014.06.1179","article-title":"Intestinal Blood Flow in Patients with Chronic Heart Failure","volume":"64","author":"Sandek","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejim.2012.11.009","article-title":"Concomitant renal and hepatic dysfunctions in chronic heart failure: Clinical implications and prognostic significance","volume":"24","author":"Poelzl","year":"2013","journal-title":"Eur. J. Intern. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/cbf.3612","article-title":"Hypoxia as a modulator of cytochromes P450: Overexpression of the cytochromes CYP2S1 and CYP24A1 in human liver cancer cells in hypoxia","volume":"39","year":"2021","journal-title":"Cell Biochem. Funct."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s40256-014-0074-3","article-title":"Severe Left Ventricular Systolic Dysfunction is Independently Associated with High On-Clopidogrel Platelet Reactivity","volume":"14","author":"Motovska","year":"2014","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jcin.2020.12.005","article-title":"Stent Thrombosis Risk over Time on the Basis of Clinical Presentation and Platelet Reactivity","volume":"14","author":"Chau","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2018.05.134","article-title":"Predictive value of the age, creatinine, and ejection fraction (ACEF) score in patients with acute coronary syndromes","volume":"270","author":"Wischnewsky","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jcin.2021.03.051","article-title":"Outcomes of Drug-Eluting Stent Thrombosis after Treatment for Acute versus Chronic Coronary Syndrome","volume":"14","author":"Yamamoto","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jacc.2017.06.047","article-title":"Risk of Arterial Thromboembolism in Patients with Cancer","volume":"70","author":"Navi","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.1055\/s-0041-1736037","article-title":"Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives","volume":"05","author":"Falanga","year":"2021","journal-title":"TH Open"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/CIRCULATIONAHA.115.018347","article-title":"Vascular Toxicities of Cancer Therapies","volume":"133","author":"Herrmann","year":"2016","journal-title":"Circulation"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1161\/CIRCULATIONAHA.115.018351","article-title":"Cardiovascular Complications of Novel Multiple Myeloma Treatments","volume":"133","author":"Li","year":"2016","journal-title":"Circulation"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1093\/eurheartj\/ehs240","article-title":"Endothelial cell repopulation after stenting determines in-stent neointima formation: Effects of bare-metal vs. drug-eluting stents and genetic endothelial cell modification","volume":"34","author":"Douglas","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/bjc.2014.491","article-title":"Effect of standard chemotherapy and antiangiogenic therapy on plasma markers and endothelial cells in colorectal cancer","volume":"111","author":"Ramcharan","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Shoji, K., Zen, K., Ookura, T., Yanishi, K., and Matoba, S. (2021). Early stent thrombosis confirmed in a cancer patient receiving regorafenib, despite triple antithrombotic therapy: A case report. BMC Cardiovasc. Disord., 21.","DOI":"10.1186\/s12872-021-01888-9"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.jcin.2014.05.035","article-title":"Outcomes after Percutaneous Coronary Intervention with Stents in Patients Treated with Thoracic External Beam Radiation for Cancer","volume":"7","author":"Liang","year":"2014","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41569-018-0118-5","article-title":"Predictors of stent thrombosis and their implications for clinical practice","volume":"16","author":"Gori","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.jacc.2007.11.061","article-title":"Subacute Coronary Stent Thrombosis in Cancer Patients","volume":"51","author":"Gross","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/CRD.0000000000000283","article-title":"Very Late Stent Thrombosis in Drug-Eluting Stents New Observations and Clinical Implications","volume":"27","author":"Wang","year":"2019","journal-title":"Cardiol. Rev."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jcin.2021.03.049","article-title":"Cancer Patients Have a Higher Risk of Thrombotic and Ischemic Events after Percutaneous Coronary Intervention","volume":"14","author":"Guo","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1161\/CIRCULATIONAHA.108.820159","article-title":"Drug-Eluting or Bare-Metal Stenting in Patients with Diabetes Mellitus","volume":"118","author":"Garg","year":"2008","journal-title":"Circulation"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1161\/01.CIR.0000091257.27563.32","article-title":"Diabetes and Vascular Disease","volume":"108","author":"Creager","year":"2003","journal-title":"Circulation"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0735-1097(03)00088-3","article-title":"Atherothrombosis, inflammation, and diabetes","volume":"41","author":"Abbate","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2337\/db16-1098","article-title":"Platelet Hyperreactivity in Diabetes: Focus on GPVI Signaling\u2014Are Useful Drugs Already Available?","volume":"66","author":"Arthur","year":"2017","journal-title":"Diabetes"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/dc06-1625","article-title":"Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation","volume":"30","author":"Geisler","year":"2007","journal-title":"Diabetes Care"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0735-1097(02)02065-X","article-title":"Coronary atherosclerosis in diabetes mellitus: A population-based autopsy study","volume":"40","author":"Goraya","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0195-668X(03)00111-8","article-title":"Clinical studies on coronary revascularization in patients with type 2 diabetes","volume":"24","author":"Mak","year":"2003","journal-title":"Eur. Heart J."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1161\/01.CIR.102.18.2180","article-title":"Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus","volume":"102","author":"Moreno","year":"2000","journal-title":"Circulation"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1161\/01.CIR.99.17.2239","article-title":"Effect of diabetes mellitus on formation of coronary collateral vessels","volume":"99","author":"Oguzhan","year":"1999","journal-title":"Circulation"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/oxfordjournals.eurheartj.a015402","article-title":"Impaired compensatory coronary artery enlargement in atherosclerosis contributes to the development of coronary artery stenosis in diabetic patients. An in vivo intravascular ultrasound study","volume":"18","author":"Vavuranakis","year":"1997","journal-title":"Eur. Heart J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/CIRCULATIONAHA.117.026788","article-title":"Optical Coherence Tomography Findings in Patients with Coronary Stent Thrombosis","volume":"136","author":"Adriaenssens","year":"2017","journal-title":"Circulation"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e002319","DOI":"10.1161\/CIRCINTERVENTIONS.114.002319","article-title":"Clinical Outcomes According to Diabetic Status in Patients Treated with Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents","volume":"8","author":"Franzone","year":"2015","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.amjcard.2010.01.007","article-title":"Long-term outcomes after percutaneous coronary intervention in patients with and without diabetes mellitus in western denmark","volume":"105","author":"Jensen","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/hrt.2009.184150","article-title":"Twelve-month outcomes in patients with diabetes implanted with a zotarolimus-eluting stent: Results from the E-Five Registry","volume":"96","author":"Jain","year":"2010","journal-title":"Heart"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s40256-018-0295-y","article-title":"Early and Late Stent Thrombosis in Patients with versus without Diabetes Mellitus Following Percutaneous Coronary Intervention with Drug-Eluting Stents: A Systematic Review and Meta-Analysis","volume":"18","author":"Yuan","year":"2018","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1001\/jama.293.12.1501","article-title":"Diabetes and Coronary Revascularization","volume":"293","author":"Flaherty","year":"2005","journal-title":"JAMA"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ccd.29913","article-title":"Diabetes mellitus is independently associated with early stent thrombosis in patients undergoing drug eluting stent implantation: Analysis from the Victorian cardiac outcomes registry","volume":"99","author":"Nogic","year":"2022","journal-title":"Catheter. Cardiovasc. Interv. Off. J. Soc. Card. Angiogr. Interv."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13019-021-01452-8","article-title":"A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients","volume":"16","author":"Ouyang","year":"2021","journal-title":"J. Cardiothorac. Surg."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12933-021-01405-4","article-title":"Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials","volume":"20","author":"Ploumen","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e002128","DOI":"10.1161\/JAHA.115.002128","article-title":"Colchicine Acutely Suppresses Local Cardiac Production of Inflammatory Cytokines in Patients with an Acute Coronary Syndrome","volume":"4","author":"Robertson","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/ejhpharm-2017-001359","article-title":"Clopidogrel non-responsiveness in patients undergoing percutaneous coronary intervention using the VerifyNow test: Frequency and predictors","volume":"26","author":"Yaseen","year":"2019","journal-title":"Eur. J. Hosp. Pharm."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0897190021997006","article-title":"Generic Clopidogrel: Has Substitution for Brand Name Plavix\u00ae Been Effective?","volume":"35","author":"Westphal","year":"2022","journal-title":"J. Pharm. Pract."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"104877","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104877","article-title":"High on-clopidogrel platelet reactivity in ischaemic stroke or transient ischaemic attack: Systematic review and meta-analysis","volume":"29","author":"Alakbarzade","year":"2020","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/ijmr.IJMR_782_17","article-title":"Aspirin & clopidogrel non-responsiveness & its association with genetic polymorphisms in patients with myocardial infarction","volume":"150","author":"Dikshit","year":"2019","journal-title":"Indian J. Med. Res."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Chen, M., Zhang, L., and Zhao, Q. (2020). The impact of cytochrome 450 and Paraoxonase polymorphisms on clopidogrel resistance and major adverse cardiac events in coronary heart disease patients after percutaneous coronary intervention. BMC Pharmacol. Toxicol., 21.","DOI":"10.1186\/s40360-019-0378-7"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2217\/pme-2018-0030","article-title":"Cytochrome 2C19 and paraoxonase-1 polymorphisms and clopidogrel resistance in ischemic heart disease patients","volume":"16","author":"Akram","year":"2019","journal-title":"Pers. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e024709","DOI":"10.1161\/JAHA.121.024709","article-title":"Sex-Specific Differences in Clinical Outcomes after Percutaneous Coronary Intervention: Insights from the TAILOR-PCI Trial","volume":"11","author":"Madan","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1111\/cts.13124","article-title":"Pharmacogenomic polygenic risk score for clopidogrel responsiveness among Caribbean Hispanics: A candidate gene approach","volume":"14","author":"Duconge","year":"2021","journal-title":"Clin. Transl. Sci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3233\/CH-190580","article-title":"A novel approach of platelet function test for prediction of attenuated response to clopidogrel","volume":"73","author":"Ezer","year":"2019","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s11239-020-02121-8","article-title":"Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel","volume":"50","author":"Cirillo","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/09537104.2018.1434311","article-title":"How does measurement of platelet P-selectin compare with other methods of measuring platelet function as a means of determining the effectiveness of antiplatelet therapy?","volume":"30","author":"Fox","year":"2019","journal-title":"Platelets"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Ko, Y.M., Kim, J.K., Park, S.-H., and Choi, R.K. (2018). Comparison of antiplatelet treatment in patients with clopidogrel nonresponders with or without carriage of CYP2C19 polymorphism. Korean J. Intern. Med., ahead of print.","DOI":"10.3904\/kjim.2017.363"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/jcpt.13665","article-title":"High-Dose Clopidogrel versus Ticagrelor in CYP2C19 intermediate or poor metabolizers after percutaneous coronary intervention: A Meta-Analysis of Randomized Trials","volume":"47","author":"Sheng","year":"2022","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Al-Rubaish, A.M., Al-Muhanna, F.A., Alshehri, A.M., Al-Mansori, M.A., Alali, R.A., Khalil, R.M., Al Faraidy, K.A., Cyrus, C., Sulieman, M.M., and Vatte, C. (2020). Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapy. BMC Cardiovasc. Disord., 20.","DOI":"10.1186\/s12872-020-01558-2"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00228-021-03224-8","article-title":"Utility of a pharmacogenetic-driven algorithm in guiding dual antiplatelet therapy for patients undergoing coronary drug-eluting stent implantation in China","volume":"78","author":"Lyu","year":"2022","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e003353","DOI":"10.1161\/CIRCGEN.121.003353","article-title":"Genotype-Guided P2Y12 Inhibitor Therapy after Percutaneous Coronary Intervention: A Bayesian Analysis","volume":"14","author":"Parcha","year":"2021","journal-title":"Circ. Genom. Precis. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e024156","DOI":"10.1161\/JAHA.121.024156","article-title":"ABCD-GENE Score and Clinical Outcomes Following Percutaneous Coronary Intervention: Insights from the TAILOR-PCI Trial","volume":"11","author":"Capodanno","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1907096","article-title":"\u2019T.; Van Der Harst, P.; Barbato, E.; Morisco, C.; Gin, R.M.T.J.; Asselbergs, F.W.; et al. A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI","volume":"381","author":"Claassens","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.gene.2018.03.007","article-title":"Association between P2RY12 gene polymorphisms and adverse clinical events in coronary artery disease patients treated with clopidogrel: A systematic review and meta-analysis","volume":"657","author":"Li","year":"2018","journal-title":"Gene"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00228-020-03024-6","article-title":"Association of FMO3 rs1736557 polymorphism with clopidogrel response in Chinese patients with coronary artery disease","volume":"77","author":"Zhu","year":"2021","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1093\/cvr\/cvz015","article-title":"Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention","volume":"115","author":"Kessler","year":"2019","journal-title":"Cardiovasc. Res."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/23\/7367\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:32:26Z","timestamp":1760131946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/23\/7367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,28]]},"references-count":116,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["jcm12237367"],"URL":"https:\/\/doi.org\/10.3390\/jcm12237367","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,28]]}}}